MorphoSys AG
NASDAQ:MOR
MorphoSys AG
NASDAQ:MOR
Price:
18.96
USD
2.43%
Market Cap:
$2.9B
Balance Sheet
Balance Sheet Decomposition
MorphoSys AG
MorphoSys AG
Balance Sheet Decomposition is not available for
MorphoSys AG
MorphoSys AG
Balance Sheet
MorphoSys AG
MorphoSys AG
Currency: EUR
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
33
|
1
|
75
|
78
|
45
|
44
|
110
|
123
|
402
|
158
|
|
| Cash |
32
|
0
|
74
|
77
|
45
|
44
|
110
|
123
|
402
|
158
|
|
| Cash Equivalents |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
114
|
0
|
70
|
87
|
314
|
228
|
981
|
870
|
505
|
524
|
|
| Total Receivables |
173
|
0
|
150
|
164
|
21
|
20
|
90
|
86
|
112
|
43
|
|
| Accounts Receivables |
15
|
0
|
13
|
11
|
18
|
15
|
83
|
76
|
91
|
32
|
|
| Other Receivables |
158
|
0
|
137
|
153
|
3
|
5
|
6
|
10
|
21
|
11
|
|
| Inventory |
1
|
0
|
0
|
0
|
0
|
0
|
10
|
21
|
24
|
62
|
|
| Other Current Assets |
2
|
0
|
13
|
12
|
9
|
11
|
17
|
33
|
45
|
27
|
|
| Total Current Assets |
322
|
0
|
308
|
341
|
389
|
304
|
1 207
|
1 133
|
1 089
|
814
|
|
| PP&E Net |
4
|
0
|
4
|
4
|
4
|
48
|
51
|
50
|
51
|
15
|
|
| PP&E Gross |
4
|
0
|
4
|
4
|
4
|
48
|
51
|
50
|
51
|
15
|
|
| Accumulated Depreciation |
12
|
0
|
15
|
16
|
15
|
16
|
18
|
20
|
21
|
23
|
|
| Intangible Assets |
39
|
0
|
61
|
60
|
44
|
41
|
69
|
838
|
887
|
844
|
|
| Goodwill |
7
|
0
|
7
|
7
|
4
|
4
|
2
|
336
|
356
|
342
|
|
| Note Receivable |
0
|
16
|
80
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
96
|
99
|
197
|
0
|
5
|
4
|
|
| Other Long-Term Assets |
3
|
0
|
4
|
3
|
3
|
1
|
134
|
200
|
9
|
7
|
|
| Other Assets |
7
|
0
|
7
|
7
|
4
|
4
|
2
|
336
|
356
|
342
|
|
| Total Assets |
426
N/A
|
0
N/A
|
464
N/A
|
415
-10%
|
539
+30%
|
496
-8%
|
1 660
+234%
|
2 556
+54%
|
2 397
-6%
|
2 026
-15%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
0
|
9
|
5
|
7
|
11
|
48
|
74
|
39
|
28
|
|
| Accrued Liabilities |
16
|
0
|
23
|
36
|
37
|
45
|
79
|
113
|
117
|
80
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
3
|
3
|
4
|
10
|
5
|
|
| Other Current Liabilities |
16
|
0
|
7
|
6
|
2
|
3
|
70
|
94
|
113
|
151
|
|
| Total Current Liabilities |
33
|
0
|
38
|
48
|
46
|
62
|
200
|
285
|
278
|
264
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
40
|
315
|
322
|
330
|
253
|
|
| Deferred Income Tax |
0
|
0
|
7
|
8
|
4
|
0
|
5
|
22
|
7
|
7
|
|
| Other Liabilities |
45
|
0
|
2
|
1
|
1
|
0
|
518
|
1 683
|
1 625
|
1 454
|
|
| Total Liabilities |
78
N/A
|
0
N/A
|
48
N/A
|
57
+18%
|
50
-11%
|
102
+102%
|
1 038
+920%
|
2 311
+123%
|
2 240
-3%
|
1 977
-12%
|
|
| Equity | |||||||||||
| Common Stock |
26
|
0
|
29
|
29
|
32
|
32
|
33
|
34
|
34
|
38
|
|
| Retained Earnings |
18
|
0
|
28
|
97
|
153
|
256
|
158
|
672
|
823
|
1 013
|
|
| Additional Paid In Capital |
318
|
0
|
428
|
439
|
620
|
628
|
749
|
833
|
834
|
938
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
14
|
0
|
15
|
12
|
10
|
8
|
5
|
3
|
2
|
2
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
53
|
115
|
88
|
|
| Total Equity |
349
N/A
|
0
N/A
|
415
N/A
|
359
-14%
|
488
+36%
|
395
-19%
|
621
+57%
|
245
-61%
|
157
-36%
|
49
-69%
|
|
| Total Liabilities & Equity |
426
N/A
|
0
N/A
|
464
N/A
|
415
-10%
|
539
+30%
|
496
-8%
|
1 660
+234%
|
2 556
+54%
|
2 397
-6%
|
2 026
-15%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
26
|
0
|
29
|
29
|
32
|
32
|
33
|
34
|
34
|
38
|
|
Switch to:
Switch to:
See Also
Discover More
